Su, Y.-C.; Wu, C.-C.; Su, C.-C.; Hsieh, M.-C.; Cheng, C.-L.; Kao Yang, Y.-H.
Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection. Cancers 2022, 14, 2118.
https://doi.org/10.3390/cancers14092118
AMA Style
Su Y-C, Wu C-C, Su C-C, Hsieh M-C, Cheng C-L, Kao Yang Y-H.
Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection. Cancers. 2022; 14(9):2118.
https://doi.org/10.3390/cancers14092118
Chicago/Turabian Style
Su, Yi-Chia, Chih-Chien Wu, Chien-Chou Su, Meng-Che Hsieh, Ching-Lan Cheng, and Yea-Huei Kao Yang.
2022. "Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection" Cancers 14, no. 9: 2118.
https://doi.org/10.3390/cancers14092118
APA Style
Su, Y.-C., Wu, C.-C., Su, C.-C., Hsieh, M.-C., Cheng, C.-L., & Kao Yang, Y.-H.
(2022). Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection. Cancers, 14(9), 2118.
https://doi.org/10.3390/cancers14092118